Please login to the form below

Not currently logged in
Email:
Password:

Sun Pharma

This page shows the latest Sun Pharma news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca launches $1bn Chinese investment fund

AstraZeneca launches $1bn Chinese investment fund

As the world’s second-largest healthcare market after the US, China has been a target for many big pharma companies, and AstraZeneca is already among the multinational drug industry’s  ... At the same time, AZ has just announced a partnership with

Latest news

More from news
Approximately 6 fully matching, plus 43 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2016 Deal Watch December 2016

    295. Novartis (Switzerland). Sun Pharma (India). Asset acquisition. Odomzo (sonidegib; hedgehog pathway inhibitor), approved in basal cell carcinoma. ... Sun Pharma. 3.5%. BSN Medical. Svenska Cellulosa. -0.7%. Claris. Baxter. -1.3%.

  • Deal Watch November 2016 Deal Watch November 2016

    Sun Pharma will also assume Biosintez's $36m debt as part of this transaction. ... acquisition - company. 78. JSC Biosintez/ Sun Pharma. Russian pharma focusing on hospital segment with 2015 revenues of approx $52m.

  • Choosing destiny Choosing destiny

    to, for example, Sun Pharma and vice-versa.

  • Deal Watch July 2016 Deal Watch July 2016

    In at numbers 2, 3 and 4 are the LEO-AstraZeneca deal with an upfront of $115m, Astellas-Cytokinetics at $95m and Almirall-Sun Pharma at $50m (see below). ... Almirall paid $50m upfront to Sun Pharma for a licence to tildrakizumab (an IL-23p19 antibody)

  • Pharma deals during April 2014 Pharma deals during April 2014

    may not be as simple as it seems. Last year the FDA imposed export bans from 20 or so plants in India and warned several others, and whilst Sun Pharma has ... is rumoured that a solution will be to replace the Ranbaxy brand with the Sun Pharma moniker

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Health editor at The Sun newspaper joins Ruder Finn Health editor at The Sun newspaper joins Ruder Finn

    Emma Morton appointed media strategist at PR firm. Emma Morton, health and science editor at UK newspaper The Sun,  is to join the London healthcare team of communications firm Ruder Fin ... Morton spent 13 years at The Sun, initially joining as a

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • How To Become an MSL – Online Training

    Michael Milane, MD, MBA DUSA Pharmaceuticals, a SUN Pharma company . Executive Director of Medical Affairs Jennifer Williams, PhD, JD, MBA, MS, RN Bard Medical Director of Medical Science Liaisons.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics